Core Viewpoint - CICC has raised the profit forecast for Uni-President China (00220) for 2025 and 2026 by 3% to 2.29 billion and 2.62 billion yuan respectively, citing the company's resilient beverage business amid increasing competition [1] Group 1: Financial Performance - The company reported 1H25 revenue of 17.087 billion yuan, a year-on-year increase of 10.6%, and a net profit attributable to shareholders of 1.287 billion yuan, up 33.2% year-on-year [2] - In 2Q25, the net profit attributable to shareholders was 685 million yuan, reflecting a year-on-year increase of 34.6% [2] Group 2: Beverage Business Performance - The beverage segment achieved a revenue increase of 7.6% year-on-year in 1H25, despite intensified competition [3] - Tea beverage revenue grew by 9.1% year-on-year in 1H25, with double-digit growth in products like Double Brew and Spring Green Tea [3] - Juice and milk tea revenues increased by 1.7% and 3.5% year-on-year respectively, indicating stable growth [3] Group 3: Cost and Profitability - The company's gross margin improved by 0.5 percentage points year-on-year in 1H25, driven by cost reductions and enhanced capacity utilization [3] - The beverage gross margin increased by 1.4 percentage points year-on-year, while the food gross margin decreased by 0.4 percentage points due to rising palm oil prices [3] - The net profit margin rose by 1.3 percentage points to 7.5% in 1H25, supported by effective cost control measures [3] Group 4: Future Outlook - The company anticipates that the beverage business may face slight pressure in 3Q due to intensified competition, but expects overall steady growth for the year [4] - The company maintains a rational competitive strategy and aims to keep its expense investment steady, which is expected to support stable profit margins in the second half of the year [4]

Group 1 - The Ministry of Transport, Ministry of Finance, and Ministry of Natural Resources have issued a plan to complete the construction and renovation of 300,000 kilometers of rural roads by 2027, aiming to establish a convenient and efficient rural road network [1] - The plan includes implementing 300,000 kilometers of repair and maintenance projects, maintaining a good road condition rate of over 70%, and carrying out safety protection projects on 150,000 kilometers of roads [1] - The initiative aims to enhance rural transportation services and support the vision of a well-structured, high-quality rural transportation system by 2035 [1] Group 2 - U.S. stock markets saw an overall increase, with the Dow Jones rising by 81.38 points (0.19%) and the Nasdaq increasing by 252.87 points (1.21%) [2] - Notable stock movements included Apple rising by 5% due to anticipated investments in U.S. manufacturing, and McDonald's gaining over 3% following better-than-expected earnings [2] - Many popular Chinese concept stocks also saw gains, with Alibaba up over 3% and NIO increasing by over 2% [2] Group 3 - The State Grid reported a record high electricity load for three consecutive days, reaching a maximum load of 1.233 billion kilowatts, an increase of 53 million kilowatts compared to last year's peak [3] - The electricity load is expected to remain above 1.2 billion kilowatts, with a potential decrease anticipated due to upcoming rainfall and cooler temperatures [3] Group 4 - The Hong Kong Monetary Authority intervened in the currency market, buying HKD 8.439 billion after the Hong Kong dollar hit the weak end of its trading band [4] - This action is part of the linked exchange rate system, where the HKMA sells USD and buys HKD to stabilize the currency [4] Group 5 - The China Photovoltaic Industry Association is soliciting opinions on the draft amendment to the Price Law, focusing on price behavior norms and regulatory mechanisms [5] - This initiative aims to reflect the demands of the photovoltaic industry and gather feedback for potential modifications [5] Group 6 - Guangnan Group's subsidiary successfully acquired land use rights in Foshan for RMB 56.16 million, expanding its meat industry chain [6] Group 7 - Caocao Travel is exploring the tokenization of real-world assets and stablecoin payments through a strategic partnership with a licensed financial institution in Hong Kong [7][8] Group 8 - Lianzhong is integrating AI technology into traditional board games, collaborating with tech companies to enhance gaming experiences [9] Group 9 - China National Pharmaceutical Group's self-developed drug TQ05105 has been included in the breakthrough therapy designation program for chronic graft-versus-host disease treatment [10] Group 10 - China Nuclear Technology expects a mid-year profit increase of no less than 15% compared to the previous year [11] Group 11 - Hengrui Medicine's product received orphan drug designation from the FDA, which may provide regulatory advantages in the U.S. market [12] Group 12 - Huaxian Optoelectronics anticipates a significant profit increase of at least 600% for the first half of 2025 [13] Group 13 - New World Development expects a mid-year profit of no less than HKD 800 million, a substantial increase from the previous year's HKD 75.4 million [14] Group 14 - Xinwei Medical expects to achieve a net profit of at least RMB 40 million in the first half of 2025, marking a turnaround from losses [15] Group 15 - Zhiyu Technology anticipates a mid-year profit increase of approximately 108.9% to 126.7% [16] Group 16 - Ningmeng Media expects to achieve a net profit of approximately RMB 10 million to 12 million in the first half of 2025, reversing previous losses [17] Group 17 - Weixin Jinke anticipates a significant profit increase of no less than RMB 200 million for the first half of 2025, reflecting a growth of at least 65% [18] Group 18 - Uni-President China reported a 33.24% increase in shareholder profit to RMB 1.287 billion for the mid-year period [19] Group 19 - BeiGene reported a net profit of USD 94.32 million for the second quarter, marking a turnaround from a loss of USD 120 million in the previous year [20] Group 20 - Maifushi expects to achieve a net profit of approximately RMB 31.8 million to 41 million in the first half of 2025, reversing a significant loss from the previous year [21]

Group 1 - South Korea will implement a temporary visa exemption policy for Chinese group tourists from September 29 to June 30 next year, which is expected to significantly boost tourism between the two countries [1] - The policy may enhance the performance of the outbound tourism industry chain, including airlines, duty-free shops, and hotels, as the capacity of Korea-China flight routes is likely to be further released [1] - The duty-free sector may benefit from the return of Chinese consumer spending, providing a growth opportunity for local retail enterprises in South Korea [1] Group 2 - Haidilao clarified rumors about transitioning to a semi-self-service model, emphasizing that service standards will remain unchanged, which helps stabilize consumer perception of the brand [2] - The incident highlights consumer concerns regarding service quality, potentially prompting the restaurant sector to reassess the sustainability of the "service premium" business model [2] - The ability of chain restaurants to manage standardized operations will become a key consideration for investors, with the industry likely accelerating its shift towards refined operations [2] Group 3 - Uni-President China reported a net profit of approximately 1.29 billion yuan for the first half of 2025, a year-on-year increase of about 33%, indicating effective product structure optimization and cost control [3] - The company's revenue for the first half of the year was approximately 17.09 billion yuan, up 10.6% year-on-year, with food and beverage segments showing growth of 8.8% and 7.6% respectively [3] - This strong performance may enhance market confidence in leading companies within the fast-moving consumer goods sector, with increased focus on new product development and channel expansion strategies [3] Group 4 - Zhenjiu Lidou Group announced the launch of a new super beer named "Bull Market," reflecting the strategic intent of traditional liquor companies to diversify their product offerings [4] - The announcement led to a 7.89% increase in the company's stock price, indicating market interest in the innovation capabilities of the liquor industry [4] - The entry of traditional liquor companies into the beer market may alter the competitive landscape, particularly as these companies leverage their distribution advantages to expand product lines [4]

Major Events - Cathay Pacific (00293) has purchased fourteen Boeing 777-9 aircraft [1] - Hengrui Medicine (01276) received FDA orphan drug designation for the combination of injection Rituximab and chemotherapy for gastric cancer or gastroesophageal junction adenocarcinoma [1] - China National Pharmaceutical Group's self-developed drug TQ05105 (JAK/ROCK inhibitor) has been included in the breakthrough therapy designation program [1] - Junshi Biosciences (02696) completed the first patient dosing in a Phase II clinical study of HLX79 injection combined with Hanli Kang® for active glomerulonephritis in China [1] - YingTai Medical (01501) plans to invest no more than 110 million yuan to establish the Huai Ge Guang Tai Fund [1] - JinJing New Energy (01783) proposed a stock split [1] Financial Data - Cathay Pacific (00293) reported a mid-term profit attributable to shareholders of 3.651 billion HKD, a year-on-year increase of 1.1%, with an interim dividend of 0.20 HKD per share [1] - Uni-President Enterprises China (00220) reported a mid-term profit attributable to shareholders of 1.287 billion CNY, a year-on-year increase of 33.24% [1] - BeiGene (06160) reported a net profit of 94.32 million USD for the second quarter, returning to profitability year-on-year [1] - Sun Hung Kai Properties (00086) issued a profit warning, expecting mid-term profit attributable to shareholders to increase to no less than 800 million HKD year-on-year [1] - Weixin Jinke (02003) issued a profit warning, expecting mid-term comprehensive net profit to be no less than 200 million CNY, a significant year-on-year increase [1] - ZhiZi Cheng Technology (09911) issued a profit warning, expecting mid-term profit attributable to shareholders to increase by approximately 108.9% to 126.7% year-on-year [1] - China Star Optoelectronics (00334) issued a profit warning, expecting a year-on-year increase of no less than 600% in profit attributable to the parent company for the first half of the year [1] - Xinli International (00732) reported a total operating revenue of approximately 1.468 billion HKD in July, a year-on-year decrease of about 3.3% [1]

Major Events - Cathay Pacific (00293) has purchased fourteen Boeing 777-9 aircraft [1] - Hengrui Medicine (01276) received FDA orphan drug designation for the combination of injection Rituximab and chemotherapy for gastric cancer or gastroesophageal junction adenocarcinoma [1] - China National Pharmaceutical Group (01177) has its self-developed drug TQ05105 (JAK/ROCK inhibitor) included in the breakthrough therapy designation program [1] - Junshi Biosciences (02696) completed the first patient dosing in a Phase II clinical study of HLX79 injection combined with Hanli Kang® for active glomerulonephritis in China [1] - YingTai Medical (01501) plans to invest no more than 110 million yuan to establish the Huai Ge Guang Tai Fund [1] - JinJing New Energy (01783) proposed a stock split [1] Financial Data - Cathay Pacific (00293) reported a mid-term profit attributable to shareholders of 3.651 billion HKD, a year-on-year increase of 1.1%, with an interim dividend of 0.2 HKD per share [1] - Uni-President Enterprises China (00220) reported a mid-term profit attributable to shareholders of 1.287 billion CNY, a year-on-year increase of 33.24% [1] - BeiGene (06160) reported a net profit of 94.32 million USD in the second quarter, returning to profitability year-on-year [1] - New World Development Company (00086) issued a profit warning, expecting mid-term profit attributable to shareholders to increase to no less than 800 million HKD year-on-year [1] - Weixin Jinkao (02003) issued a profit warning, expecting mid-term comprehensive net profit to be no less than 200 million CNY, a significant year-on-year increase [1] - ZhiZi Cheng Technology (09911) issued a profit warning, expecting mid-term profit attributable to shareholders to increase by approximately 108.9% to 126.7% year-on-year [1] - Huaxian Optoelectronics (00334) issued a profit warning, expecting a year-on-year increase of no less than 600% in profit attributable to the parent company [1] - Xinli International (00732) reported a total operating revenue of approximately 1.468 billion HKD in July, a year-on-year decrease of about 3.3% [1]

Financial Performance - Uni-President China (00220.HK) reported a net profit of RMB 1.2867 billion for the first half of 2025, an increase of 33.2% year-on-year [1] - The company's revenue for the first half of 2025 reached RMB 17.0866 billion, up 10.6% compared to the same period last year [1] - The gross profit margin improved to 34.3%, a rise of 0.5 percentage points from the previous year [1] Business Segments - The food segment generated revenue of RMB 5.3822 billion, an increase of 8.8% year-on-year, accounting for 31.5% of total revenue [1] - The beverage segment reported revenue of RMB 10.7881 billion, up 7.6% year-on-year, making up 63.1% of total revenue [1] - The overall gross profit increased from RMB 5.228 billion to RMB 5.8648 billion, a rise of 12.2% [1] Operational Insights - The increase in gross profit margin was attributed to sales growth leading to enhanced production capacity and a decline in some raw material prices [1]

Investment Rating - The report maintains an "Outperform" rating for the company, indicating a positive outlook on its performance relative to the market [2][9]. Core Insights - The company reported a strong performance in H1 2025, with revenue reaching RMB 17.087 billion, a year-on-year increase of 10.6%, and a net profit of RMB 1.287 billion, up 33.2% year-on-year, exceeding expectations [9]. - The upward revision of profit forecasts is attributed to the decline in raw material prices, improved capacity utilization, and cost optimization, with projected net profits for 2025-2027 being RMB 2.315 billion, RMB 2.579 billion, and RMB 2.843 billion respectively, reflecting year-on-year growth rates of 25%, 11%, and 10% [9]. - The company is recognized as an industry leader, with its food business driving structural upgrades in instant noodles and its beverage segment expanding its multi-category layout [9]. Financial Data and Profit Forecast - Revenue projections for the company are as follows: - 2023: RMB 28.591 billion - 2024: RMB 30.332 billion - 2025E: RMB 32.364 billion - 2026E: RMB 34.473 billion - 2027E: RMB 36.580 billion - The expected growth rates for revenue are 1.2%, 6.1%, 6.7%, 6.5%, and 6.1% respectively [3][10]. - Net profit forecasts are as follows: - 2023: RMB 1.667 billion - 2024: RMB 1.849 billion - 2025E: RMB 2.315 billion - 2026E: RMB 2.579 billion - 2027E: RMB 2.843 billion - The projected year-on-year growth rates for net profit are 36.4%, 11.0%, 25.2%, 11.4%, and 10.2% respectively [3][10]. Business Segment Performance - The food segment achieved a revenue of RMB 5.382 billion in H1 2025, with an 8.8% year-on-year growth, driven primarily by the instant noodle business [9]. - The beverage segment reported a revenue of RMB 10.788 billion, reflecting a 7.6% year-on-year increase, with notable growth in tea, juice, and milk tea categories [9]. Margin and Cost Efficiency - The company achieved a gross margin of 34.32% in H1 2025, an increase of 0.48 percentage points year-on-year, driven by lower raw material costs and improved capacity utilization [9]. - The sales expense ratio decreased to 22.08%, down 1.17 percentage points year-on-year, due to optimized expense management [9].

Performance Highlights - BeiGene (06160.HK) reported a revenue of 17.518 billion yuan for the first half of the year, a year-on-year increase of 46%; product revenue was 17.36 billion yuan, up 45.8%; net profit was 450 million yuan, turning from loss to profit [2] - Uni-President China (00220.HK) achieved approximately 17.087 billion yuan in revenue for the first half, a year-on-year increase of 10.6%; net profit was about 1.287 billion yuan, up 33.2% [2] - Zhiyu City Technology (09911.HK) announced a positive profit forecast, expecting mid-term revenue of approximately 3.135 to 3.215 billion yuan, a year-on-year increase of about 38.0% to 41.5%; net profit is expected to be around 470 to 510 million yuan, a year-on-year growth of approximately 108.9% to 126.7% [2] Earnings Forecasts - New World Development Company (00086.HK) expects mid-term net profit to increase to no less than 800 million HKD year-on-year [3] - Weizhi Jinkou (02003.HK) anticipates mid-term net profit exceeding 200 million HKD, a significant increase year-on-year [3] - Wing Chan Industrial (01596.HK) forecasts mid-term net profit of approximately 48.7 million HKD, turning from loss to profit [3] - Huaxian Optoelectronics (00334.HK) expects mid-term net profit to exceed 48.8 million HKD, a year-on-year increase of over 600% [3] - Maifushi (02556.HK) predicts mid-term net profit of approximately 31.8 to 41 million HKD, turning from loss to profit [4] - Xinwei Medical-B (06609.HK) expects mid-term net profit to exceed 40 million HKD, turning from loss to profit [5] - China Nuclear Technology (00611.HK) anticipates mid-term net profit growth of over 15% [6] Earnings Warnings - Hongxing Printing Group (00450.HK) expects mid-term net loss of approximately 49 million HKD, a significant increase year-on-year [7] - Zhongyu Land (01224.HK) forecasts mid-term net loss of approximately 40 million HKD, turning from profit to loss [7] - Beihai Group (00701.HK) anticipates mid-term net loss of 36 to 40 million HKD [8] Real Estate Sales Data - China Overseas Development (00688.HK) reported cumulative contract property sales of approximately 132 billion yuan for the first seven months, a year-on-year decrease of 18.3% [9] - Yuexiu Property (00123.HK) achieved cumulative contract sales of approximately 67.506 billion yuan for the first seven months, a year-on-year increase of about 11.7% [9] - Poly Property Group (00119.HK) reported contract sales of approximately 29.5 billion yuan for the first seven months, a year-on-year decrease of 13.49% [10] - China Overseas Hongyang Group (00081.HK) reported cumulative contract sales of 18.649 billion yuan for the first seven months, a year-on-year decrease of 12.2% [10] - Jindi Commercial Real Estate (00535.HK) reported cumulative contract sales of approximately 6.98 billion yuan for the first seven months, a year-on-year decrease of 37.37% [10] - Agile Group (03383.HK) reported pre-sale amount of approximately 5.69 billion yuan for the first seven months [11] - Hongyang Real Estate (01996.HK) reported cumulative contract sales of 3.208 billion yuan for the first seven months, a year-on-year decrease of 41.6% [12] - Zhengrong Real Estate (06158.HK) reported cumulative contract sales of approximately 2.701 billion yuan for the first seven months, a year-on-year decrease of 30.6% [12] - Jingrui Holdings (01862.HK) reported cumulative contract sales of approximately 571 million yuan for the first seven months, a year-on-year decrease of 52.54% [13] Company News - CITIC Securities (06030.HK) reported that its subsidiary, Huaxia Fund, achieved revenue of 4.258 billion yuan and net profit of 1.123 billion yuan in the first half, with assets under management totaling 285.1237 billion yuan [14] - Xinyi International (00732.HK) reported a cumulative operating revenue of approximately 9.566 billion HKD for the first seven months, a year-on-year decrease of about 5.3% [15] - Heng Rui Pharmaceutical (01276.HK) received orphan drug designation from the US FDA for its injection of Rikan Trastuzumab combined with Adebali for gastric cancer or gastroesophageal junction adenocarcinoma indications [15] - Fuhong Hanlin (02696.HK) completed the first patient dosing in a Phase II clinical study of HLX79 injection combined with Hanlikang® for active renal glomerulonephritis in China [15] - China Biopharmaceutical (01177.HK) announced that its self-developed TQ05105 (JAK/ROCK inhibitor) has been included in the breakthrough therapy designation program for the treatment of chronic graft-versus-host disease [15] Buyback Activities - HSBC Holdings (00005.HK) repurchased approximately 1.65 billion HKD worth of about 1.714 million shares at a price of 95.8 to 96.75 HKD [16] - Hang Seng Bank (00011.HK) spent approximately 22.6347 million HKD to repurchase 200,000 shares at a price of 112.8 to 113.6 HKD [17] - Yum China (09987.HK) repurchased approximately 6.264 million HKD worth of 16,800 shares at a price of 369.8 to 376 HKD [17]

Uni-President China Holdings Ltd. 統一企業中國控股有限公司 公司董事會提名委員會之職權規定 經董事會訂立於 2007 年 11 月 23 日 組成 第一次修訂：2012 年 03 月 27 日 第二次修訂：2018 年 12 月 14 日 第三次修訂：2025 年 8 月 6 日 釋義 在此職權規定中，除上下文另有規定外，下列詞彙作如下解釋： 1 （「董事會」） 指公司董事會； （「委員會」） 指公司董事會提名委員會； （「公司」） 指統一企業中國控股有限公司； （「董事」） 指本公司董事； （「集團」） 指公司及其附屬公司； （「獨立非執行董事」） 指獨立非執行董事； （「上市規則」） 指香港聯合交易所有限公司證券上市規則； （「高級管理人員」） 指依據上市規則被視爲高級管理人級別的人。 權益披露及投票 5 委員會每一名成員須向委員會披露任何存在於或因委員會決定的事項而產生的個人財務利益 或潛在利益衝突。除公司章程容許的情况外，委員會成員不得就任何其本人或聯繫人(聯繫人 按上市規則所作的定義相同)擁有重大權益的委員會决議進行投票；在確定是否有足够的法定 人數出席考慮有關决議 ...

2025年上半年度業績發佈 2025年8月6日 免責聲明 本演示材料所載資料之用途爲僅供閣下個人參考，該等資料如有變更，恕不另 行通知。對于本演示材料所載資料的公平性、準確性、完整性或正確性，我們 均無作出任何明示或隱含的聲明或保證，閣下亦不應對此加以依賴。我們無意 提供，而閣下亦不應依賴本演示材料，爲本公司之財務或經營狀况或前景的完 整或全面分析。對于使用本演示材料所載資料或其內容或基于本演示材料所載 資料而引致的任何損失或損害，本公司或其任何聯繫人士、顧問或代表概不承 擔任何疏忽或其他責任。 本演示材料包含前瞻性陳述，該等陳述反映本公司對未來發展及財務狀况的現 有看法。由於該等陳述涉及風險及不明確性，閣下不應過分依賴該等前瞻性陳 述，而我們無法保證實際業績與該等前瞻性陳述相符。本公司亦不會有義務就 新資訊、未來發展或其他原因而公開更新或對于任何前瞻性陳述作出修改。 本演示材料不構成購買或認購證券或其他金融工具的要約或邀請或投資意見的 提供，而且其中任何部分均不得作爲與該等證券或金融工具相關的任何合同、 承諾或投資决定的基礎或加以依賴，且本演示材料亦不構成對本公司證券或金 融工具的推薦意見。 2 2 * 股 ...